Sg Americas Securities, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 20, 2020	SELL	$0.52 - $0.92 $87,011 - $153,943	-167,330 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$0.6 - $2.31 $50,040 - $192,654	-83,400 Reduced 33.26%	167,330 $100,000
Q4 2019 Jan 28, 2020	BUY	$0.63 - $2.27 $157,959 - $569,157	250,730 New	250,730 $569,000
Q1 2018 May 03, 2018	SELL	$0.76 - $1.32 $32,775 - $56,926	-43,126 Closed	0 $0
Q4 2017 Jan 24, 2018	BUY	$1.1 - $1.54 $2,038 - $2,853	1,853 Added 4.49%	43,126 $50,000
Q3 2017 Nov 07, 2017	BUY	$1.19 - $1.43 $49,114 - $59,020	41,273	41,273 $54,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.